Mutual Up-Regulation of Thyroid Hormone and Parathyroid Hormone Receptors in Rat Osteoblastic Osteosarcoma 17/2.8 Cells¹

Abstract

PTH and thyroid hormone (T(3)) stimulate anabolic and catabolic processes in bone predominantly by acting on osteoblasts. Both inadequate and excessive secretion of either hormone can result in clinical bone disorders. In addition, T(3) and PTH related peptide (PTHrP) have multiple effects on a wide number of other tissues modulating both cell differentiation and proliferation. To address the question of whether there might be functional mutual regulation of T(3) receptors (TR) and PTH/PTHrP receptors (PTHR), we studied their expression and receptor-mediated intracellular effects in rat osteoblastic osteosarcoma (ROS) 17/2.8 cells. PTHR were up-regulated by T(3) pretreatment (10(-)(10)-10(-)(6) M) in ROS 17/2.8 cells in a dose-dependent manner. T(3) pretreatment increased both PTH-induced cyclic AMP response element binding protein (CREB) phosphorylation and PTH-induced intracellular calcium transients, and further decreased PTH-induced down-regulation of alkaline phosphatase activity, suggesting that there are functional consequences of the PTHR up- regulation. Pretreatment with PTH (10(-)(10)-10(-)(6) M) or PTHrP (10(-)(9) M) for 3-4 days resulted in a dose-dependent up-regulation of TR in ROS 17/2.8 cells. cAMP analogues or a calcium ionophore were able to mimic the effect of PTH on TR binding, suggesting that either the cAMP-signaling pathway or Ca(2+) could be involved in PTH-induced up-regulation of the TR. These observations provide a novel example of mutual interactions between nuclear receptors and membrane receptors and may have significant implications for the regulation of bone remodeling in health and disease.

Application and prospect of trabecular bone score in differentiated thyroid cancer patients receiving thyrotropin suppression therapy

“…T3 binds to thyroid hormone receptor alpha (TRα), the main receptor expressed in bone, and stimulates osteoblasts directly or indirectly through a variety of growth factors and cytokines ( 37 – 39 ). Thyroid hormone receptors are also expressed in osteoclasts, and their interaction with T3 leads to an increase in the number and activity of osteoblasts, resulting in enhanced bone resorption.…”

Osteogenesis Hormonal Regulation: Review

“…Впоследствии во время резорбции кос ти T3 увеличивает экспрессию важных факторов дифференцировки линии остеокласта, таких как, интерлейкин 6 и простагландин E2 [74]. Кроме того, T3 действует синергически с остеокластогенными гормонами -паращитовидным гормоном (ПТГ) и витамином D [78,79]. Продемонстрировано, что T3 увеличивает экспрессию мРНК лиганда активатора рецептора ядерного фактора-λ β (RANKL) в остеобласте, который активирует RANK, присутствующий в предшественниках остеокластов.…”